Ethics and Innovation: The Theranos Case

This chapter explores the classification of companies like Theranos within Silicon Valley and the broader biotech sector, examining the intricate connections with Stanford and prominent investors. It raises critical ethical questions regarding corporate responsibility and the troubling culture within the startup ecosystem that often allows questionable practices to flourish. Ultimately, the discussion reflects on the implications of high-profile fraud cases and their impact on investor confidence and regulatory scrutiny.